newsfeed-en
@SachsAssociates
6. Jan 2021 via Twitter
André Heeg is an expert in digital venture building and innovation with a focus on digital healthcare and D2C models. e-Meet André at #Sachs_EHTFMore info @ https://t.co/HI7OAD4QYO pic.twitter.com/A1EiMoliUy— Sachs Associates (@SachsAssociates) January 6, 2021
@SachsAssociates
5. Jan 2021 via Twitter
Alex Zhavoronkov, PhD, is the founder and CEO of InSilico Medicine(@InSilicoMeds), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development. e-Meet Alex at #Sachs_EHTFMore info @ https://t.co/HI7OAD4QYO #Sachs_EHTF pic.twitter.com/37NLG3xPrp— Sachs Associates (@SachsAssociates) January 5, 2021…
@SachsAssociates
5. Jan 2021 via Twitter
Tim Haines is Chairman and Managing Partner at Abingworth LLP, a leading global life sciences venture investment firm. e-Meet Tim at #Sachs_ELSFMore info @ https://t.co/YXBF2fUYBz pic.twitter.com/JyMjDN37N5— Sachs Associates (@SachsAssociates) January 5, 2021
@SachsAssociates
4. Jan 2021 via Twitter
Matthias is an entrepreneurial-minded, result-driven, and communication-strong pharma business development leader with more than 10 years of international experience.e-Meet Matthias at #Sachs_ELSFMore info @ https://t.co/YXBF2fUYBz pic.twitter.com/Qqyh0mmTIs— Sachs Associates (@SachsAssociates) January 4, 2021
@SachsAssociates
4. Jan 2021 via Twitter
Martin-Immanuel Bittner is the CEO of Arctoris(@arctoris), the world's first fully automated drug discovery platform that he co-founded in 2016. e-Meet Martin-Immanuel at #Sachs_EHTFMore info @ https://t.co/HI7OAD4QYO pic.twitter.com/DmftY1g7dH— Sachs Associates (@SachsAssociates) January 4, 2021
@SachsAssociates
4. Jan 2021 via Twitter
Dr. Birner joined TVM Capital in 2000 as an investment manager. Now he is responsible for TVM Capital Life Science’s overall investment strategy and global fund operations.e-Meet Hubert at #Sachs_ELSFMore info @ https://t.co/YXBF2fUYBz pic.twitter.com/afUWqag8Ep— Sachs Associates (@SachsAssociates) January 4, 2021
@SachsAssociates
23. Dec 2020 via Twitter
Season's greetings from Sachs Team pic.twitter.com/YUCTsOVXJw— Sachs Associates (@SachsAssociates) December 23, 2020
@SachsAssociates
23. Dec 2020 via Twitter
Paul Hermant is a corporate & finance partner at Bird & Bird LLP, specialised in the life sciences sector and based in Brussels. He heads the firmwide corporate life sciences group.e-Meet Paul at #Sachs_ELSFMore info @ https://t.co/YXBF2fUYBz pic.twitter.com/6de0LC1yIQ— Sachs Associates (@SachsAssociates) December 23, 2020
@SachsAssociates
23. Dec 2020 via Twitter
Samuel Levy invests in commercial-stage health technology businesses at Lauxera Capital Partners, a firm he created in 2020. e-Meet Samuel at #Sachs_EHTFMore info @ https://t.co/HI7OAD4QYO pic.twitter.com/xtVeYnHKBH— Sachs Associates (@SachsAssociates) December 23, 2020
@SachsAssociates
22. Dec 2020 via Twitter
Eric Halioua, President & CEO at PDC*line Pharma is a serial entrepreneur that combines strong strategic, technological, managerial, fund-raising and deal-making experience.e-Meet Eric at #Sachs_ELSFMore info @ https://t.co/YXBF2fUYBz pic.twitter.com/R5uSiFfV3Q— Sachs Associates (@SachsAssociates) December 22, 2020